Glenmark Pharmaceuticals Limited has uploaded the audio recording of its Q3 FY26 earnings call on its official website, following regulatory compliance requirements under SEBI regulations.

Earnings Call Recording Availability

The company has made available the complete audio recording of its Q3 FY26 earnings call held on February 2, 2026, on its website. The recording can be accessed at the company's investor relations section under earnings call recordings.

Regulatory Compliance

The upload was conducted pursuant to Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company has formally notified both BSE Limited and National Stock Exchange of India Limited about the availability of the recording.

Corporate Communication Details

The notification was signed by Harish Kuber, Company Secretary & Compliance Officer, and digitally authenticated on February 2, 2026. The communication was sent to both major stock exchanges where the company's shares are listed.

The earnings call recording provides investors and stakeholders with access to management discussions regarding the company's Q3 FY26 financial performance and strategic outlook.

Glenmark Pharmaceuticals Limited has announced its quarterly earnings call to discuss Q3FY26 financial results, scheduled for Monday, February 02, 2026. The pharmaceutical company has formally notified stock exchanges BSE and NSE about this investor communication event under regulatory compliance requirements.

Earnings Call Schedule and Access Details

The Q3FY26 results discussion will be conducted as a conference call with specific timing and access arrangements for investors and analysts.

Global Dial-in Access Numbers

The company has provided multiple international access numbers to accommodate global investor participation:

Registration and Contact Information

Participants can pre-register online through the company's designated registration portal. For any clarifications regarding the earnings call, investors can contact Utkarsh Gandhi at utkarsh.gandhi3@glenmarkpharma.com or phone +91 22 4018 9232.

Regulatory Compliance and Recording

The earnings call announcement was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Harish Kuber signed the official communication to both stock exchanges on January 22, 2026. The company has confirmed that the complete recording of the earnings call will be available on its official website within 24 hours of the call's completion, ensuring accessibility for stakeholders who cannot participate in the live session.